| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| REGENXBIO | 13 | - | +1,33 % | ||
| CORMEDIX | 11 | 10 | -13,22 % | ||
| INVIVYD | 11 | 3 | 0,00 % | ||
| TANGO THERAPEUTICS | 9 | 3 | 0,00 % | ||
| TENAYA THERAPEUTICS | 7 | - | 0,00 % | ||
| ALNYLAM PHARMACEUTICALS | 6 | 9 | +1,52 % | ||
| KURA ONCOLOGY | 6 | 2 | -2,08 % | ||
| AQUESTIVE THERAPEUTICS | 6 | 2 | 0,00 % | ||
| ALTIMMUNE | 6 | - | +3,74 % | ||
| SILENCE THERAPEUTICS | 6 | - | +1,27 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:15 | ARGENX SE - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12:06 | Citizens reiterates Kura Oncology stock rating on strong launch | 4 | Investing.com | ||
| 11:42 | Citizens reiterates Aquestive stock rating on clear FDA path | 1 | Investing.com | ||
| 11:42 | Citizens raises GH Research stock price target on phase 3 progress | 1 | Investing.com | ||
| 11:34 | Aquestive Therapeutics: Citizens sieht klaren Weg für FDA-Zulassung und bestätigt Rating | 1 | Investing.com Deutsch | ||
| 10:58 | Alnylam bets on Tenaya RNAi tech, and other licensing news | 4 | pharmaphorum | ||
| 10:50 | ANAVEX LIFE SCIENCES CORP: Strukturelle Ruhe, klarer Fokus | 2 | Maximilian Berger | ||
| 10:30 | BioNTech-Aktie: Schockmeldung - droht der massive Rückschlag? | Hebelschein-Spekulant | |||
| 10:17 | BEONE MEDICINES (06160): GRANT OF RESTRICTED SHARE UNITS | 1 | HKEx | ||
| 09:54 | Barclays initiates Regeneron stock with Overweight on Dupixent growth | 3 | Investing.com | ||
| 09:46 | Barclays startet Regeneron mit "Overweight" - Wachstumstreiber Dupixent | 2 | Investing.com Deutsch | ||
| 07:06 | argenx SE: argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline | 5 | GlobeNewswire (USA) | ||
| 03:29 | ArriVent Biopharma, Inc. Full Year Loss Increases | 1 | RTTNews | ||
| 01:30 | uniQure used 'distorted comparison' in Huntington's asset trial: FDA official | 11 | Seeking Alpha | ||
| 00:54 | Truist reiterates CorMedix stock rating on steady guidance | 3 | Investing.com | ||
| 00:54 | Stifel reiterates Buy on Contineum stock, keeps $29 price target | 1 | Investing.com | ||
| 00:30 | Morgan Stanley cuts Veracyte stock price target on valuation methodology | 4 | Investing.com | ||
| 00:18 | Regenxbio stock: Clear Street reiterates Buy on gene therapy data | 1 | Investing.com | ||
| 00:18 | Clear Street raises Erasca stock price target on combination trial deal | 1 | Investing.com | ||
| 00:01 | Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 | 24 | The Motley Fool |